Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: polyrotaxane

September 3, 2025 CD as API / CD derivatives / Pharma applications

Toxic effects and cellular uptake of functional polyrotaxanes.

The little we have learned and the many unknowns still waiting to be discovered. Cyclodextrins are commonly used as excipients

Continue reading

August 7, 2025 Uncategorized

Topologically-crosslinked hydrogels based on γ-cyclodextrins

Biomimetic strategies are increasingly the focus of materials scientists looking to improve or invent new materials. Topology is an important

Continue reading

July 10, 2025 Drug delivery / Pharma applications

Cyclodextrin-based rotaxanes as a versatile platform for biological and medicinal applications

Mechanically interlocked molecules (MIMs) such as rotaxanes and catenanes attract significant interest due to their unique structures and dynamic properties.

Continue reading

June 3, 2025 Drug delivery / Pharma applications / Uncategorized

Cyclodextrin-Based Supramolecular Carrier for Cancer Proteinaceous Antigen

Protein-based vaccines are gaining attention as a promising platform for vaccines because they are highly safe and induce humoral and

Continue reading

April 22, 2025 CD as API / Pharma applications

Supramolecular polyrotaxane-based nano-theranostics enable cancer-cell stiffening for enhanced T-cell-mediated anticancer immunotherapy

Redox-responsive Methyl-β-cyclodextrin (MeβCD)-based supramolecular polyrotaxanes (MSPs) were fabricated: the amphiphilic diselenide-bridged axle polymer was loaded by MeβCD via the host-guest

Continue reading

April 1, 2024 CD derivatives / Non-pharma applications / Pharma applications

Preparation and Application of Polyrotaxane Cross-Linking Agent Based on Cyclodextrin in Gel Materials Field

The cross-linking point of a conventional chemical cross-linking agent is fixed. Therefore, gels that are prepared with a conventional cross-linking

Continue reading

November 27, 2023 Life sciences

Differences in the Intracellular Localization of Methylated β-Cyclodextrins-Threaded Polyrotaxanes Lead to Different Cellular States

Activation of autophagy represents a potential therapeutic strategy for the treatment of diseases that are caused by the accumulation of

Continue reading

May 12, 2022 CD as API / Pharma applications

Cothreading of Unmodified and Monoazidated β-Mixed cyclodextrins in polyrotaxanes for Niemann Pick disease

To establish a method for the orthogonal chemical functionalization of β-cyclodextrin (β-CD)-based polyrotaxane (PRX), unmodified and monoazidated β-CDs (N3-β-CDs) were

Continue reading

December 7, 2021 Drug delivery / Pharma applications

γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis

Anterior uveitis is a sight-threatening inflammation inside the eyes. Conventional eye drops for anti-inflammatory therapy need to be administered frequently

Continue reading

June 11, 2021 CD as API / CD derivatives / Pharma applications

Weakly acidic carboxy group-grafted β-cyclodextrin-threaded acid-degradable polyrotaxanes for modulating protein interaction and cellular internalization

To improve the therapeutic potential of β-cyclodextrin (β-CD)-threaded acid-degradable polyrotaxanes (β-CD PRXs) in cholesterol-related metabolic disorders, the effect of carboxylation

Continue reading

Posts pagination

1 2 Next Posts»

Recent Posts

  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Comparative study of thiolated and alkenylated functionalized β-CDs as highly mucopenetrating and mucoadhesive drug delivery systems.
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (63)
  • CD as API (339)
  • CD derivatives (395)
  • Cosmetics and toilettry (49)
  • Diagnosis (11)
  • Drug delivery (774)
  • E-ducation (63)
  • Environmental (129)
  • Events (232)
  • Food (217)
  • Gene delivery (19)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (390)
  • Other industrial use (104)
  • Pharma applications (1,156)
  • Supramolecular systems (40)
  • Uncategorized (140)

Top Posts

  • Surface-Engineered Amino-Graphene Oxide Aerogel Functionalized with Cyclodextrin for Desulfurization and Denitrogenation in Oil Refining
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • Cyclodextrin and KR12-Lipopeptide Interactions
  • Recent papers on Cyclodextrins in Nature
  • Lanosterol eye drops for cataract treatment
  • Engineered Self-Assembly of Amphiphilic Cyclodextrin Conjugates for Drug Encapsulation
  • Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
  • Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation
  • Comparison of cholesterol complexation with β-cyclodextrin derivatives: A combined theoretical and experimental study
  • Gamma-cyclodextrin as molecular chaperone in protein delivery and stabilization

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,792 other subscribers
 

Loading Comments...